The clinical information you need, at your fingertips.

CMS will limit monthly out-of-pocket cost for select GLP-1 medications for eligible Medicare Part D beneficiaries starting in July. . .

Phase 2b trials suggest additive efficacy without added safety concerns in patients with Crohn’s disease or ulcerative colitis who've failed multiple therapies. . .

Virtual visits within established practices may support more judicious prescribing without added follow-up. . .

Widespread adoption of life‑saving HIV therapy was associated with substantial downstream increases in syphilis incidence, likely through behavioral and population‑level effects. . .

Foundation-led review suggests metabolic treatments may also improve skin disease. . .

Higher dietary intake was associated with clinically meaningful improvements in health status and cough symptoms in adults with COPD. . .

Two studies mapped fat and muscle; they found that body composition predicts cardiometabolic disease and mortality better than BMI. . .

When clinicians discussed anxiety as an overtuned survival response rather than a genetic condition, they found the approach more useful. . .

Routine vaginal-only testing overlooks a substantial proportion of chlamydia and gonorrhea infections in women. . .